Phase I trial of VSV oncolytic virus in patients with hepatocellular carcinoma or liver metastases

Trial Profile

Phase I trial of VSV oncolytic virus in patients with hepatocellular carcinoma or liver metastases

Recruiting
Phase of Trial: Phase I

Latest Information Update: 20 Jan 2015

At a glance

  • Drugs Oncolytic viruses (Primary)
  • Indications Liver cancer; Liver metastases
  • Focus Adverse reactions
  • Sponsors Omnis Pharma
  • Most Recent Events

    • 20 Jan 2015 New trial record
    • 12 Jan 2015 Omnis Pharmaceuticals is conducting this phase I monotherapy trial, according to an AstraZeneca media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top